Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4Breast 3Other hematologic neoplasm 2Gynecologic 2Endocrine 2Sarcoma 1NET 1Lymphoid 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Muscle Weakness 1

Interventions

Cyclophosphamide 173Rituximab 165Specimen Handling 118Biopsy 94Magnetic Resonance Spectroscopy 91Vincristine 88Doxorubicin 83Prednisone 81fludarabine 71venetoclax 70obinutuzumab 63Lenalidomide 56ibrutinib 55Dexamethasone 55Cytarabine 49Methotrexate 47acalabrutinib 44Etoposide 43CT-P10 42blinatumomab 38fludarabine phosphate 35Bendamustine Hydrochloride 35Gemcitabine 33prednylidene 32zanubrutinib 31deltacortene 31pembrolizumab 30glofitamab 30Calcium Dobesilate 30Nivolumab 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Positron-Emission Tomography × Lymphoid × 90 days × Clear all
NCT06819475 2026-05-18

Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors

St. Jude Children's Research Hospital

Phase NA Recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Neoplasms, Muscle Weakness, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡